Optimax Holdings Sdn Bhd (0222) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Optimax Holdings Sdn Bhd (0222) has a cash flow conversion efficiency ratio of 0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM5.25 Million ≈ $1.32 Million USD) by net assets (RM81.36 Million ≈ $20.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Optimax Holdings Sdn Bhd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Optimax Holdings Sdn Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Optimax Holdings Sdn Bhd for a breakdown of total debt and financial obligations.
Optimax Holdings Sdn Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Optimax Holdings Sdn Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Transat AT Inc
TO:TRZ
|
0.178x |
|
Huadian Ener-B
SHG:900937
|
0.067x |
|
DMCC SPECIALITY CHEMICALS LIMITED
NSE:DMCC
|
0.033x |
|
Vakrangee Limited
NSE:VAKRANGEE
|
0.093x |
|
PolyPid
NASDAQ:PYPD
|
-2.876x |
|
Vinyl Group Ltd
AU:VNL
|
-0.277x |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
-0.032x |
|
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762
|
0.035x |
Annual Cash Flow Conversion Efficiency for Optimax Holdings Sdn Bhd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Optimax Holdings Sdn Bhd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Optimax Holdings Sdn Bhd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | RM73.33 Million ≈ $18.41 Million |
RM23.86 Million ≈ $5.99 Million |
0.325x | -12.62% |
| 2023-12-31 | RM67.96 Million ≈ $17.06 Million |
RM25.30 Million ≈ $6.35 Million |
0.372x | -14.70% |
| 2022-12-31 | RM61.99 Million ≈ $15.56 Million |
RM27.05 Million ≈ $6.79 Million |
0.436x | +27.98% |
| 2021-12-31 | RM57.74 Million ≈ $14.50 Million |
RM19.69 Million ≈ $4.94 Million |
0.341x | +32.19% |
| 2020-12-31 | RM50.22 Million ≈ $12.61 Million |
RM12.96 Million ≈ $3.25 Million |
0.258x | -64.59% |
| 2019-12-31 | RM24.24 Million ≈ $6.09 Million |
RM17.66 Million ≈ $4.43 Million |
0.728x | +17.39% |
| 2018-12-31 | RM20.79 Million ≈ $5.22 Million |
RM12.90 Million ≈ $3.24 Million |
0.621x | +24.72% |
| 2017-12-31 | RM16.34 Million ≈ $4.10 Million |
RM8.13 Million ≈ $2.04 Million |
0.498x | -26.68% |
| 2016-12-31 | RM12.22 Million ≈ $3.07 Million |
RM8.29 Million ≈ $2.08 Million |
0.679x | -- |
About Optimax Holdings Sdn Bhd
Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye d… Read more